Valeant again boosts cash in offer for Allergan

Fri May 30, 2014 2:48pm EDT
 
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article
[-] Text [+]

May 30 (Reuters) - Valeant Pharmaceuticals International Inc said on Friday that it would increase the cash component in its takeover bid for Botox-maker Allergan Inc for the second time this week, contingent on the two sides negotiating.

Valeant said it would pay $72 in cash - up from $58.30 on Wednesday - and 0.83 share of Valeant stock for each Allergan share. (Reporting by Rod Nickel in Winnipeg, Manitoba; Editing by Chris Reese)